<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03687151</url>
  </required_header>
  <id_info>
    <org_study_id>18-DSP-04</org_study_id>
    <nct_id>NCT03687151</nct_id>
  </id_info>
  <brief_title>Population-based Cancer Observatory</brief_title>
  <acronym>cancer observ</acronym>
  <official_title>Population-based Cancer Observatory of the French Region Sud-Provence-Alpes-Côte d'Azur Recruiting Incident Cases of Cancer Since 2005</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nice</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nice</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cancer is the leading cause of death in Western countries. In France cancer control plans
      (National screening programmes) and recommendations for the management of cancer patients
      (multidisciplinary team meetings), have been implemented. Evaluating the effectiveness of
      these policies aiming for improved prevention and management is essential. However to conduct
      such an evaluation, a baseline reference requiring ongoing, reliable and complete data
      collection is necessary and can be used for epidemiological research.

      There is no cancer registry in the French Region Sud-Provence-Alpes-Côte d'Azur. In view of
      this situation, the regional Health Agency appointed the public health department of the Nice
      Côte d'Azur University and the Centre for computerized pathology data collection
      (CRISAP-PACA) to develop a Cancer Observatory. Since 2005, the public health department
      collects data concerning invasive and in situ cancers from all the histopathology labs in the
      French Region Sud-Provence-Alpes-Côte d'Azur, gathered in the CRISAP-PACA, and transmits
      incidence cancer rates to the regional Health Agency. In 2007, a quality control procedure,
      comparing a random sample of data collected by the Cancer Observatory with pathology lab
      reports, confirmed the validity of the collected data with fewer than 3% in disagreement with
      the report's conclusions. In 2008, the estimated completeness of cancer records collected
      from histopathology laboratories was higher than 90% for new cases of breast and colorectal
      cancer within the age range concerned by the screening programme. Since 2012, public and
      private hospitals treating cancer patients as well as the regional cancer network ONCOPACA,
      coordinating multiple team meetings, have been contacted to transmit to the public health
      department cases of cancer without histological diagnosis. In addition, patients with cancer
      have been geolocated to study the influence of environmental exposures on the occurrence of
      cancers (patients living near of waste incinerator, highways).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2005</start_date>
  <completion_date type="Anticipated">December 31, 2050</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2050</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>number of each cancer of the French Region Sud-Provence-Alpes-Côte d'Azur</measure>
    <time_frame>50 years</time_frame>
    <description>each cancer is definite by :number of Date of diagnosis, Tumor location, Histology, ADICAP codes, CIM-O codes, Age, Gender and Geolocation.
number of classification of cancer.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <condition>Cancer</condition>
  <arm_group>
    <arm_group_label>patients with a diagnosis of invasive or in situ cancer</arm_group_label>
    <description>patients with a diagnosis of invasive or in situ cancer living in the French Region Sud-Provence-Alpes-Côte d'Azur since 2005</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>non intervention / observationnal</intervention_name>
    <description>non intervention / observationnal</description>
    <arm_group_label>patients with a diagnosis of invasive or in situ cancer</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patient with cancer
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All subjects with a diagnosis of invasive or in situ cancer living in the French
             Region Sud-Provence-Alpes-Côte d'Azur.

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>eugenia MARINE BARJOAN, PH</last_name>
    <phone>33492035635</phone>
    <email>marine-barjoan.e@chu-nice.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>laurent BAILLY, PH</last_name>
    <phone>33492035635</phone>
    <email>bailly.l@chu-nice.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Nice University Hospital</name>
      <address>
        <city>Nice</city>
        <zip>06000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>eugenia MARINE BARJOAN, PH</last_name>
      <phone>33492035635</phone>
      <email>marine-barjoan.e@chu-nice.fr</email>
    </contact>
    <contact_backup>
      <last_name>laurent BAILLY, PH</last_name>
      <phone>33492035635</phone>
      <email>bailly.l@chu-nice.fr</email>
    </contact_backup>
    <investigator>
      <last_name>eugenia MARINE BARJOAN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>September 20, 2018</study_first_submitted>
  <study_first_submitted_qc>September 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 27, 2018</study_first_posted>
  <last_update_submitted>September 25, 2018</last_update_submitted>
  <last_update_submitted_qc>September 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

